MR

Mahendra Raojibhai Patel

Director Director DIN 00479962
DIN 00479962 First appointment Jan 2005 Primary industry Pharma
Unlock full profile Investments · shareholding · contact details
Past companies 2 historical roles
Total affiliations 2 Since Jan 2005
Shareholding value •••• Premium profile

About Mahendra Raojibhai Patel

Data last updated:

Mahendra Raojibhai Patel was a Director at Emcure Pharmaceuticals Limited (2005–2011) and Director at Apothecon Pharmaceuticals Private Limited (2007–2011). The companies operate in Pharma.

DIN 00479962
Primary Designation Director
Industry Pharma
First Appointment 12 Jan 2005

Previous companies

CompanyDesignationAppointmentFoundedRevenueStatus
Emcure Pharmaceuticals Limited L24231PN1981PLC024251
Director12 Jan 20051981₹9,216 Cr (FY 2026)Active
Director14 May 20072007₹263 Cr (FY 2025)Active

Explore Director's current and past company associations Uncover their professional journey today!

Directorship timeline

Open interactive timeline →
Emcure Pharmaceuticals Limited
Apothecon Pharmaceuticals Private Limited
Premium access

Shareholding and investment profile for Mahendra Raojibhai Patel

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Mahendra Raojibhai Patel

Mahendra Raojibhai Patel was first appointed on 12 Jan 2005 as Director at Emcure Pharmaceuticals Limited. The most recent appointment on record is 14 May 2007 at Apothecon Pharmaceuticals Private Limited.

Mahendra Raojibhai Patel held 2 earlier board appointments: Emcure Pharmaceuticals Limited (Director, 12 Jan 2005 to 29 Apr 2011); Apothecon Pharmaceuticals Private Limited (Director, 14 May 2007 to 21 May 2011).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available